Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III biosimilarity study of Rechon Insulin Human Soluble vs Humulin Regular in type 1 diabetes
2016-004691-22Phase 3Completed
- Sponsor
- Rechon Life Science
- Start
- Jun 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of regular human insulin in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Rechon Life Science. Primary endpoint: Binding antibodies against human insulin (proportion of patients). Started Jun 2017; status: completed.
02
Drugs
regular human insulin
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2016-004691-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004691-22.